SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-145434
Filing Date
2024-05-23
Accepted
2024-05-23 07:18:55
Documents
15
Period of Report
2024-05-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823505d8k.htm   iXBRL 8-K 25867
2 EX-99.1 d823505dex991.htm EX-99.1 12128
6 GRAPHIC g823505g50l73.jpg GRAPHIC 4289
  Complete submission text file 0001193125-24-145434.txt   175601

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tngx-20240523.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tngx-20240523_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tngx-20240523_pre.xml EX-101.PRE 11708
18 EXTRACTED XBRL INSTANCE DOCUMENT d823505d8k_htm.xml XML 3766
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39485 | Film No.: 24975194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)